I now have comprehensive textbook content. Let me compile the full answer:
IV Fluids - MD Anesthesia Final Practical Viva Guide
Sources: Miller's Anesthesia 10e (Chapter 43), Morgan & Mikhail's Clinical Anesthesiology 7e, Medscape IV Fluids Review
HOW TO PRESENT AN IV FLUID IN VIVA
When the examiner puts a bag of IV fluid in front of you, follow this structured approach - every time, without fail:
"Sir/Ma'am, this is a bag of [Name]. It is a [crystalloid/colloid], [isotonic/hypotonic/hypertonic] solution. Its composition is... Its osmolality is... Its pH is... It is used for... Key clinical considerations are..."
This structure shows you know the pharmacology, not just the name. The examiner will stop you and ask questions along the way - that's expected.
PART 1 - THE MASTER COMPOSITION TABLE
(Memorize this - it is the core of every IV fluid viva)
| Fluid | Na⁺ (mEq/L) | Cl⁻ (mEq/L) | K⁺ (mEq/L) | Ca²⁺ (mEq/L) | Buffer | Glucose | Osmolality (mOsm/L) | pH | Type |
|---|
| Plasma | 138-142 | 97-107 | 4-5 | 4.5-5 | HCO₃⁻ 24 | - | 285-295 | 7.4 | - |
| 0.9% NS | 154 | 154 | 0 | 0 | None | 0 | 308 | 5.0 | Isotonic |
| Ringer's Lactate (RL) | 130 | 109 | 4 | 3 | Lactate 28 | 0 | 273-275 | 6.5 | Isotonic |
| D5W | 0 | 0 | 0 | 0 | None | 50 g/L | 252 (effective 0) | 4.0 | Hypotonic |
| DNS (D5 + 0.9% NS) | 154 | 154 | 0 | 0 | None | 50 g/L | 560 | 4.5 | Hypertonic |
| 3% NaCl | 513 | 513 | 0 | 0 | None | 0 | 1026 | 5.0 | Hypertonic |
| 0.45% NaCl (Half NS) | 77 | 77 | 0 | 0 | None | 0 | 154 | 5.0 | Hypotonic |
| Sterofundin ISO | 140 | 127 | 4 | 2.5 | Acetate 24 + Malate 5 | 0 | ~309 | 5.1-5.9 | Isotonic |
| 5% Albumin | 130-160 | 130-160 | <1 | 0 | None | 0 | 309 | 6.4-7.4 | Isotonic colloid |
| 6% HES (Hydroxyethyl Starch) | 154 | 154 | 0 | 0 | None | 0 | 310 | 5.5 | Isotonic colloid |
| Gelofusine (4%) | 154 | 125 | 0 | 0 | None | 0 | 308 | 7.4 | Isotonic colloid |
| Dextran 40 (10%) | 154 | 154 | 0 | 0 | None | 0 | 311 | 4.0-6.5 | Hypertonic colloid |
PART 2 - INDIVIDUAL FLUID PRESENTATIONS
1. Normal Saline (0.9% NaCl)
How to present:
"This is 0.9% Normal Saline. It is an isotonic, unbalanced crystalloid. It contains Na⁺ 154 mEq/L and Cl⁻ 154 mEq/L. Osmolality is 308 mOsm/L, pH is 5.0. It distributes to the extracellular compartment - approximately 25% remains intravascular, 75% moves to the interstitium."
Key facts:
- Called "normal" but is not physiologically normal - plasma Cl⁻ is 97-107 mEq/L; NS has 154 mEq/L (supraphysiologic)
- The excess chloride reduces the Strong Ion Difference (SID) → causes hyperchloremic, non-anion gap metabolic acidosis with large volumes
- 1 L NS gives ~308 mOsm of solute - stays in ECF
Indications:
- Hypovolemia, hemorrhage resuscitation
- Hypochloremic, hypokalemic metabolic alkalosis (vomiting, NGT suction)
- Blood transfusion diluent (compatible; RL causes Ca²⁺-mediated clotting)
- Drug dilution (many drugs incompatible with RL)
- Correction of hyponatremia (relative to hypotonic NS)
Contraindications / cautions:
- Avoid large volumes in: renal failure, hyperchloremia, hypernatremia
- Avoid if at risk of hyperchloremic acidosis (trauma, massive resuscitation)
- Not ideal for maintenance - causes fluid retention (no buffer mechanism)
Viva trap question: "Why is NS pH 5.0 if it contains only NaCl?" - Because dissolved CO₂ from the atmosphere forms carbonic acid during sterilization/storage.
2. Ringer's Lactate (RL) / Hartmann's Solution
How to present:
"This is Ringer's Lactate, also called Hartmann's solution. It is an isotonic, balanced crystalloid. Composition: Na⁺ 130, Cl⁻ 109, K⁺ 4, Ca²⁺ 3 mEq/L, with lactate 28 mEq/L as buffer. Osmolality 273-275 mOsm/L, pH 6.5. It most closely mimics plasma composition among commonly available fluids."
Why it is "balanced": The reduced Na⁺ and Cl⁻ (relative to NS) are compensated by lactate anion. When metabolized by the liver, lactate → HCO₃⁻ (1:1), preventing acidosis.
Key facts (Miller's Anesthesia 10e):
- Lactate metabolized primarily by hepatic oxidation or gluconeogenesis at up to 200 mmol/hour
- Contains racemic D- and L-lactate (D-lactate in trace amounts - concerns about encephalopathy not confirmed at clinical doses)
- Avoid in severe liver failure - lactate cannot be metabolized
- Slightly hypotonic (275 vs 285-295 mOsm/L of plasma) - minimal free water effect
- Does not cause hyperchloremic acidosis
- Contains Ca²⁺ - incompatible with blood transfusion (Ca²⁺ chelates citrate anticoagulant, can cause clotting in giving set)
- Contains K⁺ 4 mEq/L - use with caution in hyperkalemia (renal failure, burns)
Indications:
- Fluid resuscitation (surgical losses, burns, trauma, diarrhea)
- Preferred intraoperative maintenance fluid
- Burns (Parkland formula: 4 mL/kg/% BSA burned in first 24h, half in first 8h)
- GI losses (closest match to intestinal fluid composition)
- Hypovolemia in most routine surgical cases
Contraindications:
- Severe liver failure (cannot metabolize lactate)
- Hyperkalemia (contains K⁺ 4 mEq/L - though clinically minor)
- Blood transfusion via same IV line
- Head injury (slightly hypotonic - theoretical concern of cerebral edema; use NS instead)
3. D5W (5% Dextrose in Water)
How to present:
"This is 5% Dextrose in Water - D5W. It contains 50 grams of glucose per litre in sterile water. Initial osmolality is 252 mOsm/L, but once glucose is metabolized, it becomes effectively free water. pH is 4.0. It is functionally hypotonic."
Key facts:
- 1 L D5W provides 200 kcal (not meaningful caloric support - maintenance glucose only)
- Once glucose is taken up by cells: distributes as free water → 1/12 remains intravascular, 8/12 goes intracellular, 3/12 to interstitium
- Glucose 5 g/dL = 278 mmol/L → same as glucose in plasma but as a bolus this rapidly equilibrates
- Do not use for resuscitation - minimal intravascular volume expansion
Indications:
- Hypoglycemia
- Hypernatremia (provides free water to dilute Na⁺)
- DKA (after initial NS resuscitation, when glucose < 250 mg/dL - to prevent hypoglycemia while continuing insulin)
- Maintenance fluid to provide calories and prevent ketosis (often used as D5 in 0.45% NS or D5 in 0.225% NS for maintenance)
- Vehicle for IV medications (e.g., amiodarone infusion)
Contraindications:
- Head injury (hypotonic → worsens cerebral edema)
- Acute stroke
- Trauma (free water worsens edema)
- Burns (hypovolemia worsens)
- Liver failure (impaired glucose metabolism)
- Never use for resuscitation - no oncotic/effective osmotic pressure
4. DNS (Dextrose Normal Saline = D5 + 0.9% NS)
How to present:
"This is DNS - Dextrose Normal Saline, containing 5% dextrose in 0.9% normal saline. It is a hypertonic solution with osmolality approximately 560 mOsm/L. Na⁺ 154, Cl⁻ 154, glucose 50 g/L. pH ~4.5."
Key facts:
- The dextrose component adds 252 mOsm/L on top of NS's 308 mOsm/L → hypertonic initially
- Once glucose is metabolized → effectively becomes 0.9% NS
- Provides both sodium and calories - used when both fluid and limited energy are needed
Indications:
- Maintenance fluid in paediatrics (classic: 4-2-1 rule maintenance often uses D5/0.45% NS)
- Post-operative maintenance when caloric support needed along with electrolyte replacement
- Hypoglycemia with mild hyponatremia
- Patients who are NPO for extended periods
Cautions:
- Same hyperchloremic acidosis risk as NS in large volumes
- Hyperglycemia risk (monitor glucose, especially diabetics and post-cardiac surgery)
5. Sterofundin ISO (Balanced Crystalloid)
How to present:
"Sterofundin ISO is a balanced, isotonic crystalloid. Its composition closely mimics plasma: Na⁺ 140, Cl⁻ 127, K⁺ 4, Ca²⁺ 2.5 mEq/L, with acetate 24 and malate 5 mEq/L as buffers. Osmolality ~309 mOsm/L, pH 5.1-5.9. It is similar to PlasmaLyte."
Why it is superior to NS (per Miller's Anesthesia):
- Chloride level (127) is much closer to plasma (97-107) - less risk of hyperchloremic acidosis
- Uses acetate and malate instead of lactate - metabolized by liver, muscle, heart
- Acetate has faster metabolism than lactate (300 mmol/h vs 200 mmol/h)
- Does not require hepatic metabolism predominantly - useful in liver failure
- Does not contain Ca²⁺ → compatible with blood transfusion (unlike RL)
- Near-physiologic SID → maintains acid-base balance
Comparison with RL:
| Feature | RL | Sterofundin ISO |
|---|
| Buffer | Lactate | Acetate + Malate |
| Ca²⁺ | Yes (3 mEq/L) | Yes (2.5 mEq/L) |
| Blood compatible | No | No |
| Liver metabolism needed | Yes (lactate) | Less (acetate/malate metabolized widely) |
| Useful in liver failure | Cautious | Better |
| Osmolality | 275 mOsm/L | 309 mOsm/L |
Indications:
- General perioperative fluid replacement
- Preferred when large volumes needed - less acidosis risk than NS
- When hepatic lactate metabolism is impaired
- Increasingly replacing NS in ICU and OR
6. 3% NaCl (Hypertonic Saline)
How to present:
"This is 3% Sodium Chloride, a hypertonic saline solution. It contains Na⁺ 513, Cl⁻ 513 mEq/L. Osmolality 1026 mOsm/L - approximately 3.5 times that of plasma. It is a highly concentrated hypertonic solution administered in small volumes via central venous access."
Mechanism of action:
- Creates a strong osmotic gradient → draws free water from cells into the intravascular space
- Reduces intracellular volume → reduces cerebral edema
- Rapidly corrects hyponatremia
Indications:
- Severe symptomatic hyponatremia (seizures, coma, Na⁺ < 120 mEq/L with symptoms)
- Raised intracranial pressure / cerebral edema (alternative to mannitol; preferred in some units)
- Neurosurgery (TBI, SAH)
- After cardiac surgery with hyponatremia
Critical rules:
- Must be given via central venous catheter (peripheral extravasation → tissue necrosis)
- Rate of correction: max 8-10 mEq/L per 24 hours (risk of osmotic demyelination syndrome / central pontine myelinolysis if corrected too fast)
- Monitor serum Na⁺ every 2-4 hours during infusion
- Do not use in hypernatremia, heart failure, renal failure
Viva pearl: "What is the risk of rapidly correcting hyponatremia with 3% NaCl?" → Osmotic demyelination syndrome (ODS), previously called central pontine myelinolysis - myelin sheaths in pons rupture due to rapid osmotic shifts; causes quadriplegia, dysarthria, dysphagia.
PART 3 - COLLOIDS
Classification of Colloids
COLLOIDS
│
├── NATURAL
│ └── Albumin (4-5%, 20-25%)
│
└── SYNTHETIC
├── Gelatins (Gelofusine, Haemaccel)
├── Hydroxyethyl Starch (HES) - Voluven, Volulyte
└── Dextrans (Dextran 40, Dextran 70)
Why Colloids Expand Plasma Volume Better Than Crystalloids
Colloids contain large molecules (molecular weight > 30,000 Da) that cannot cross the capillary membrane under normal conditions → they remain in the intravascular space → generate colloid osmotic (oncotic) pressure → retain fluid intravascularly.
1:3 rule (old teaching): 1 L crystalloid expands plasma by ~250-300 mL; 1 L colloid expands plasma by ~700-1000 mL. However, Miller's notes that in inflammation/sepsis, the glycocalyx is damaged, colloids leak out, and this advantage is lost.
7. Albumin (5% and 25%)
How to present:
"Albumin is a natural colloid derived from pooled human plasma. The 5% albumin solution is iso-oncotic, with osmolality ~309 mOsm/L. The 25% albumin is hyperoncotic and draws fluid from the interstitium into the intravascular space. Na⁺ 130-160 mEq/L."
| Property | 5% Albumin | 25% Albumin |
|---|
| Oncotic pressure | ~20 mmHg (= plasma) | ~70 mmHg (hyperoncotic) |
| Volume effect | 1:1 (1L in = 1L expansion) | 1:4 to 1:5 (draws extra fluid) |
| Use | Volume replacement | Hypoalbuminemia, HRS, SBP |
Indications:
- Spontaneous bacterial peritonitis (SBP) with cirrhosis
- Hepatorenal syndrome (HRS)
- Large volume paracentesis (>5L) - prevents paracentesis-induced circulatory dysfunction
- Burns (after first 24h, replacing colloid loss)
- Hypoalbuminemia when serum albumin < 2 g/dL with clinical manifestations
- SAFE trial: No harm vs NS in ICU; may benefit patients with TBI (trend toward harm with albumin in TBI)
Disadvantages:
- Expensive
- Risk of viral transmission (though heat-treated)
- Anaphylactoid reactions (rare)
8. Hydroxyethyl Starch (HES) - Voluven 6%, Volulyte
How to present:
"Voluven is 6% Hydroxyethyl Starch in 0.9% NaCl. HES is a synthetic polysaccharide derived from waxy maize starch. It has a molecular weight of ~130 kDa. It is an isotonic colloid with good plasma expansion properties."
Pharmacology:
- Cleared by amylases (serum, tissue) → excreted renally
- C2:C6 ratio and degree of substitution determine half-life and renal clearance
- Voluven (130/0.4) has lower molecular weight and degree of substitution than older HES → less tissue accumulation
Indications:
- Hypovolemia and plasma volume expansion
- Perioperative volume replacement
Contraindications (critical for viva - MHRA/EMA restrictions 2023):
- Banned/severely restricted in: sepsis, renal impairment, ICU patients, intracranial surgery
- 6Cs/CHEST trial evidence: HES associated with increased AKI and need for renal replacement therapy, increased mortality in septic patients
- Do not use in: critical illness, sepsis, renal failure, liver failure, intracranial bleeding
Viva answer on HES: "I would not use HES in this septic ICU patient because the 6S and CHEST trials showed increased AKI and mortality with HES compared to Ringer's acetate in sepsis."
9. Gelatin Solutions (Gelofusine, Haemaccel)
How to present:
"Gelofusine is a 4% succinylated gelatin solution in 0.9% NaCl. Molecular weight ~30,000 Da. Na⁺ 154, Cl⁻ 125 mEq/L. Osmolality 308 mOsm/L, pH 7.4. Haemaccel is a 3.5% polygeline in electrolyte solution."
| Property | Gelofusine | Haemaccel |
|---|
| Gelatin type | Succinylated | Urea-linked polygeline |
| Ca²⁺ | 0 | 6.25 mEq/L |
| Blood compatible | Yes | No (Ca²⁺ present) |
| Anaphylaxis risk | Low | Low (higher than gelofusine) |
| Duration of effect | 3-4 hours | 3-4 hours |
Key points:
- Cheaper and more available than albumin
- Smaller molecules → leak across capillaries faster → shorter duration of effect
- Lower anaphylaxis risk than dextrans
- No effect on coagulation (unlike dextrans and HES)
- Not restricted like HES - can use in wider range of patients
10. Dextrans (Dextran 40, Dextran 70)
How to present:
"Dextran is a synthetic polysaccharide colloid. Dextran 40 is a 10% solution in NS (MW ~40,000 Da); Dextran 70 is a 6% solution (MW ~70,000 Da). Both have osmolality ~310 mOsm/L."
Unique properties:
- Anti-thrombotic / anti-sludging effects: Dextran 40 reduces red cell aggregation, improves microcirculation - used in peripheral vascular surgery, free flap surgery
- Coats platelets and vessel walls → inhibits coagulation - risk of bleeding
- Excreted renally - can cause tubular obstruction (dextran nephropathy)
Side effects:
- Anaphylaxis - highest risk among colloids (1:3000 to 1:50,000)
- Coagulopathy (max dose 1.5 g/kg/day for Dextran 70; 20 mL/kg for Dextran 40)
- Interfere with blood cross-matching (coat RBCs - blood bank must be aware)
- Dextran nephropathy with high doses
- Pulmonary edema
PART 4 - IV PARACETAMOL (PCM) INFUSION
How to Present:
"This is Perfalgan or IV Paracetamol - acetaminophen 10 mg/mL in 100 mL vial (i.e., 1 gram in 100 mL). It is an analgesic and antipyretic for IV use. It is given as a 15-minute infusion."
Composition:
- Paracetamol 10 mg/mL (1 g/100 mL)
- Mannitol as excipient (for solubility)
- pH: 5.5 (adjusted with hydrochloric acid/NaOH)
- Osmolality: ~290 mOsm/L
Dosing:
| Patient | Dose | Frequency | Max Daily |
|---|
| Adult ≥ 50 kg | 1 g (100 mL) | Every 4-6 hours | 4 g/day |
| Adult < 50 kg | 15 mg/kg | Every 4-6 hours | 60 mg/kg/day |
| Child 10-50 kg | 15 mg/kg | Every 4-6 hours | 60 mg/kg/day |
| Child < 10 kg | 7.5 mg/kg | Every 4-6 hours | 30 mg/kg/day |
Administration: Infuse over 15 minutes (slow infusion reduces peak concentration-related side effects).
Mechanism of Action:
- Inhibits prostaglandin synthesis centrally (COX-1 and COX-2 in CNS - weak peripheral effect)
- Acts on endocannabinoid system (AM404 metabolite activates TRPV1 channels)
- May act on serotonergic descending pain pathways
- No peripheral anti-inflammatory action (unlike NSAIDs) - no COX inhibition in peripheral tissues at clinical doses
Advantages over oral PCM in perioperative setting:
- Faster Tmax (end of infusion vs 30-60 min for oral)
- Reliable absorption (no GI uncertainty in perioperative period)
- Can be given when patient is NPO
- Opioid-sparing effect: reduces morphine requirement by 20-30%
- No GI side effects, no platelet effects (unlike NSAIDs)
- Safe in renal impairment (unlike NSAIDs)
Indications (perioperative):
- Part of multimodal analgesia protocol
- Post-operative pain (mild-moderate)
- Antipyresis in ICU
- Opioid-sparing strategy (reduces PONV, respiratory depression risk)
Contraindications / Cautions:
- Hepatic impairment / active liver disease - reduce dose or avoid
- Alcoholism (increased NAPQI formation)
- G6PD deficiency (relative)
- Paracetamol poisoning: NAPQI accumulates → hepatic necrosis → treat with N-acetylcysteine (NAC)
- Drug interactions: warfarin (prolonged INR with chronic use), isoniazid (increases NAPQI)
Hepatotoxicity Mechanism (must know):
Normal: Paracetamol → sulfation/glucuronidation (safe) + small % → NAPQI → immediately conjugated by glutathione
Overdose: Glutathione depleted → NAPQI accumulates → centrilobular hepatic necrosis
Treatment: NAC - replenishes glutathione stores
PART 5 - CRYSTALLOID vs COLLOID: THE KEY VIVA COMPARISON
| Feature | Crystalloid | Colloid |
|---|
| Molecule size | Small | Large (>30,000 Da) |
| Capillary crossing | Yes - freely | No (normally) |
| Intravascular stay | 25-30% (15-20 min) | 70-100% (hours) |
| Volume expansion | 3-4L needed per 1L plasma expansion | ~1L needed |
| Edema risk | Higher | Lower |
| Cost | Very low | High |
| Anaphylaxis | None | Possible |
| Coagulopathy | None | HES, Dextran |
| Acidosis | NS → hyperchloremic | Minimal |
| Effect on COP | Reduces | Maintains/increases |
| In sepsis (inflamed glycocalyx) | Redistributes rapidly | Also leaks - benefit lost |
Per Miller's Anesthesia 10e: "No clear consensus exists on which IV fluid is associated with best clinical outcomes in the perioperative setting."
PART 6 - POSSIBLE VIVA QUESTIONS & IDEAL ANSWERS
Q1: Why does large volume NS cause metabolic acidosis but RL does not?
NS has Cl⁻ 154 mEq/L (supraphysiologic). Adding excess Cl⁻ reduces the Strong Ion Difference (SID = Na⁺ - Cl⁻). Per Stewart's model, a lower SID forces dissociation of water to H⁺ and OH⁻, producing acidosis - specifically a normal anion gap, hyperchloremic metabolic acidosis. RL has Cl⁻ only 109 mEq/L, with lactate as the compensating anion; lactate is metabolized to HCO₃⁻, maintaining or slightly raising pH.
Q2: Why is RL incompatible with blood?
RL contains Ca²⁺ 3 mEq/L. Blood products are anticoagulated with citrate, which chelates Ca²⁺. When RL runs in the same IV line, the Ca²⁺ in RL competes with citrate, potentially overcoming the anticoagulation and causing clot formation in the IV tubing. Use NS or Sterofundin (Ca²⁺-free) with blood.
Q3: Why is D5W contraindicated in head injury?
D5W distributes as free water once glucose is metabolized (it has no effective osmoles). Free water crosses the blood-brain barrier and enters brain cells down the osmotic gradient → worsens cerebral edema and raises ICP. In head injury, use isotonic fluids (NS or balanced crystalloids, kept isotonic or slightly hypertonic).
Q4: What is the 4-2-1 rule?
Holliday-Segar formula for maintenance fluid rate:
- First 10 kg: 4 mL/kg/hour
- Next 10 kg (10-20 kg): 2 mL/kg/hour
- Each kg above 20 kg: 1 mL/kg/hour
Example: 25 kg child → (10×4) + (10×2) + (5×1) = 40 + 20 + 5 = 65 mL/hour
Q5: What is Sterofundin and why is it considered better than NS?
Sterofundin ISO is a balanced crystalloid with composition closest to plasma - Na⁺ 140, Cl⁻ 127 (vs NS Cl⁻ 154), buffered with acetate and malate. It maintains acid-base balance, does not cause hyperchloremic acidosis, is metabolized widely (not just liver), and has near-physiologic osmolality (309 mOsm/L). It is preferred in large-volume resuscitation where acid-base preservation matters.
Q6: When would you use 25% albumin vs 5% albumin?
5% albumin is iso-oncotic - used for volume replacement when you want to maintain COP without drawing extra fluid from tissues (e.g., burns after 24h, post-paracentesis). 25% albumin is hyperoncotic - it actively draws fluid from the interstitium into the vascular space - used when you want to reduce tissue edema while expanding plasma volume - e.g., hepatorenal syndrome, hypoalbuminemia with ascites, severe malnutrition with anasarca.
Q7: Why is HES no longer recommended in critically ill patients?
The 6S trial (NEJM 2012) in severe sepsis showed HES (130/0.42) vs Ringer's acetate → significantly higher 90-day mortality and higher need for renal replacement therapy with HES. The CHEST trial (NEJM 2012) in ICU patients showed HES (130/0.4) vs NS → significantly higher rates of acute kidney injury requiring renal replacement therapy. Result: EMA and MHRA restricted HES use in 2023 - banned in ICU/sepsis/renal failure patients.
Q8: What is the opioid-sparing effect of IV paracetamol?
IV paracetamol reduces morphine consumption by approximately 20-30% in the postoperative period when used as part of multimodal analgesia. This translates to reduced opioid-related side effects: less PONV, less sedation, better respiratory function, earlier mobilization. It works synergistically with NSAIDs, regional blocks, and ketamine.
Q9: What is the antidote for paracetamol overdose and how does it work?
N-acetylcysteine (NAC). Mechanism: NAC is a precursor to glutathione. It replenishes depleted glutathione stores, allowing NAPQI (the toxic intermediate metabolite of paracetamol formed via CYP2E1) to be safely conjugated and excreted. NAC is most effective within 8-10 hours of ingestion. Even given late (>24h), it has a hepatoprotective role.
Q10: What fluid would you choose for a 60 kg patient undergoing 4-hour abdominal surgery?
I would choose Ringer's Lactate (or Sterofundin ISO) as the primary maintenance and replacement fluid. RL is balanced, isotonic, closest to plasma composition, does not cause hyperchloremic acidosis, and is appropriate for replacing third-space and insensible losses. I would supplement with IV paracetamol 1 g in 100 mL for multimodal analgesia, and use colloid (gelatin or albumin) only if hemodynamic instability persists after adequate crystalloid loading. I would guide resuscitation with goal-directed fluid therapy using stroke volume variation (SVV) if an arterial line is in place.
QUICK MEMORY AID
"BORN SAD" - Crystalloids to know:
- Balanced = Sterofundin, PlasmaLyte
- Osmolality comparison: NS 308 > Sterofundin 309 > RL 275 > D5W 252
- RL = No blood transfusion (Ca²⁺ issue)
- NS = Hyperchloremic acidosis in large volumes
- Sodium 154 in NS; 130 in RL; 140 in Sterofundin; 513 in 3% NaCl
- Acidosis from NS - hyperchloremic, normal anion gap
- D5W = Free water once metabolized - avoid in head injury
Colloids order of anaphylaxis risk: Dextrans > HES > Gelatins > Albumin (least risk)
References: Miller's Anesthesia 10e, Chapter 43 (IV Fluid and Electrolyte Therapy); Morgan & Mikhail's Clinical Anesthesiology 7e; Medscape IV Fluids Review; SAFE Trial (NEJM 2004); 6S Trial (NEJM 2012); CHEST Trial (NEJM 2012)